Comparison of 3D Ultrasound and Standard Imaging for Breast Assessment

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to compare the effectiveness of a customized 3D ultrasound device against the standard 2D ultrasound in visualizing breast tumors and features. It will recruit 30 female participants who are scheduled for routine mammography and ultrasound assessments. During the procedure, additional 3D ultrasound images will be captured to evaluate their diagnostic capabilities. The study is led by Dr. Aaron Fenster at Western University, utilizing a commercial ultrasound machine adapted for 3D imaging.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult Patients who are scheduled for screening ABUS
* Adults Patients who are scheduled for short term follow-up with ABUS.
* Must be at least 18 years of age or older.
* Must be proficient in English (reading/writing).

Exclusion Criteria:

* Patients with breast implants.
* Patients with contraindication for ABUS.
* Patients who cannot tolerate ABUS.

Where it's running

• St. Joseph's Hospital
  London, Ontario, Canada Recruiting

Study contacts

• Study coordinator: Anat Kornecki, MD
• Email: Anat.Kornecki@sjhc.london.on.ca
• Phone: 519-646-6100

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Autonomous Dual-Arm Breast Ultrasound: Scanning Performance and Diagnostic Agreement

  This study tests an autonomous dual-arm robotic breast ultrasound system to see if its scans and diagnostic impressions match those from conventional handheld ultrasound in adults undergoing breast screening.

  Recruiting at 3 sites Huazhong University of Science and Technology · Shiyan, Hubei and 3 other locations · NCT07915050

• Dalpiciclib plus hormone therapy for early HR+/HER2- breast cancer

  This trial tests whether adding dalpiciclib at two different doses and durations to standard hormone therapy helps people with early HR+/HER2- breast cancer.

  Recruiting Phase 2 Fujian Cancer Hospital · Fuzhou, Fujian and 1 other locations · NCT07581834

• Benchmark and performance test for AI reading breast ultrasound images

  This project will test whether multimodal AI models can read breast ultrasound images to help classify normal, benign, and malignant findings for people who have had breast ultrasound.

  Recruiting Peking Union Medical College Hospital · Beijing · NCT07500428

• How local breast cancer treatments affect side effects and quality of life in Chinese patients

  This project will test how surgery and related treatments (chemotherapy, radiation, hormone or targeted therapy) affect side effects and daily quality of life for people with early-stage breast cancer in China.

  Recruiting Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Beijing, Beijing Municipality and 2 other locations · NCT07010939

• Predicting outcomes for advanced breast cancer patients treated with CDK4/6 inhibitors and endocrine therapy

  This study is trying to see how well different CDK4/6 inhibitors combined with hormone therapy work for people with advanced breast cancer and how safe they are.

  Recruiting at 24 sites Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · Aviano and 23 other locations · NCT06805812

• Understanding breast cancer risk factors and outcomes in Florida

  This study is trying to understand the different risk factors and outcomes of breast cancer in men and women in Florida by collecting samples and survey information from new patients at breast clinics.

  Recruiting at 2 sites Memorial Sloan Kettering Cancer Center · Los Angeles, California and 2 other locations · NCT06780176

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.